Trial Profile
A Historically-controlled, Multi-center Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule, Prograf Injection) and Methotrexate Combination Therapy for Prevention of GVHD in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Ciclosporin; Methotrexate
- Indications Graft-versus-host disease
- Focus Adverse reactions; Therapeutic Use
- Sponsors Astellas Pharma
- 03 Feb 2016 New trial record